Fig. 1
From: Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
Whole blood miRNA levels in patients at T0, T1 and T2. The dot plots show the relative levels of oncogenic miR-19a, − 21 and − 22 (a), and tumor suppressor miR-20a, − 127 and -200b (b). Comparisons were performed (for each time point separately) using the Mann-Whitney U test and the corresponding p-values of significant differences are indicated in the graphs (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001). (HD: healthy donor; T0: before adjuvant therapy; T1: after adjuvant therapy; T2: at 2 years follow up)